These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 25797915)

  • 1. Relationship between endothelial dysfunction and osteoprotegerin, vitamin D, and bone mineral density in patients with rheumatoid arthritis.
    Delgado-Frías E; López-Mejias R; Genre F; Ubilla B; Gómez Rodríguez-Bethencourt MA; González-Díaz A; de Vera-González AM; González-Rivero AF; Díaz-González F; González-Gay MA; Ferraz-Amaro I
    Clin Exp Rheumatol; 2015; 33(2):241-9. PubMed ID: 25797915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoprotegerin and RANKL in the pathogenesis of rheumatoid arthritis-induced osteoporosis.
    Xu S; Wang Y; Lu J; Xu J
    Rheumatol Int; 2012 Nov; 32(11):3397-403. PubMed ID: 22057136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of abdominal adiposity and body composition with endothelial dysfunction in patients with rheumatoid arthritis.
    Delgado-Frías E; González-Gay MA; Muñiz-Montes JR; Gómez Rodríguez-Bethencourt MA; González-Díaz A; Díaz-González F; Ferraz-Amaro I
    Clin Exp Rheumatol; 2015; 33(4):516-23. PubMed ID: 26148347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Serum sRANKL, sRANKL/OPG Ratio, and Other Bone Turnover Markers with the Estimated 10-Year Risk of Major and Hip Osteoporotic Fractures in Rheumatoid Arthritis: A Cross-Sectional Study.
    Nava-Valdivia CA; Ponce-Guarneros JM; Saldaña-Cruz AM; Corona-Sanchez EG; Ramirez-Villafaña M; Perez-Guerrero EE; Murillo-Saich JD; Contreras-Haro B; Vazquez-Villegas ML; Gonzalez-Ponce F; Bonilla-Lara D; Jacobo-Cuevas H; Centeno-Valadez JD; Echeverria-Gonzalez G; Cerpa-Cruz S; Alcaraz-Lopez MF; Cardona-Muñoz EG; Salazar-Paramo M; Gonzalez-Lopez L; Gamez-Nava JI
    Biomed Res Int; 2021; 2021():5567666. PubMed ID: 34497849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D deficiency and low bone mineral density in native Chinese rheumatoid arthritis patients.
    Chen J; Liu W; Lin Q; Chen L; Yin J; Huang H
    Int J Rheum Dis; 2014 Jan; 17(1):66-70. PubMed ID: 24131858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in polycystic ovary syndrome: relationships to insulin resistance and endothelial dysfunction.
    Pepene CE; Ilie IR; Marian I; Duncea I
    Eur J Endocrinol; 2011 Jan; 164(1):61-8. PubMed ID: 20974706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density.
    Rossini M; Viapiana O; Adami S; Fracassi E; Idolazzi L; Dartizio C; Povino MR; Orsolini G; Gatti D
    Clin Exp Rheumatol; 2015; 33(1):77-83. PubMed ID: 25438096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble receptor activator of NFkappa B-ligand and osteoprotegerin in rheumatoid arthritis - relationship with bone mineral density, disease activity and bone turnover.
    Oelzner P; Franke S; Lehmann G; Eidner T; Müller A; Wolf G; Hein G
    Clin Rheumatol; 2007 Dec; 26(12):2127-2135. PubMed ID: 17541498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of endothelial dysfunction in patients with rheumatoid arthritis.
    Sarli B; Baktir AO; Cebicci M; Dogan Y; Demirbas M; Kurtul S; Saglam H; Akpek M; Sahin O; Arinc H
    Angiology; 2014 Oct; 65(9):778-82. PubMed ID: 24078515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypovitaminosis D is associated with endothelial dysfunction in patients with non-dialysis chronic kidney disease.
    Zhang QY; Jiang CM; Sun C; Tang TF; Jin B; Cao DW; He JS; Zhang M
    J Nephrol; 2015 Aug; 28(4):471-6. PubMed ID: 25515034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoprotegerin and uremic osteoporosis in chronic hemodialysis patients.
    Moldovan D; Rusu C; Potra A; Moldovan I; Patiu IM; Gherman-Caprioara M; Kacso IM
    Int Urol Nephrol; 2017 May; 49(5):895-901. PubMed ID: 28161839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoprotegerin concentrations relate independently to established cardiovascular disease in rheumatoid arthritis.
    López-Mejias R; Ubilla B; Genre F; Corrales A; Hernández JL; Ferraz-Amaro I; Tsang L; Llorca J; Blanco R; González-Juanatey C; Gonzalez-Gay MA; Dessein PH
    J Rheumatol; 2015 Jan; 42(1):39-45. PubMed ID: 25362655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D Status, Disease Activity, and Endothelial Dysfunction in Early Rheumatoid Arthritis Patients.
    Caraba A; Crişan V; Romoşan I; Mozoş I; Murariu M
    Dis Markers; 2017; 2017():5241012. PubMed ID: 29200598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased risk for bone loss in women with systemic sclerosis: a comparative study with rheumatoid arthritis.
    Kilic G; Kilic E; Akgul O; Ozgocmen S
    Int J Rheum Dis; 2016 Apr; 19(4):405-11. PubMed ID: 24283757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent relationship of osteoprotegerin concentrations with endothelial activation and carotid atherosclerosis in patients with severe rheumatoid arthritis.
    Dessein PH; López-Mejias R; González-Juanatey C; Genre F; Miranda-Filloy JA; Llorca J; González-Gay MA
    J Rheumatol; 2014 Mar; 41(3):429-36. PubMed ID: 24488413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lumbar spine bone mineral density predicts endothelial reactivity in patients with systemic lupus erythematosus.
    Mak A; Ling LH; Ho RC; Gong L; Cheak AA; Yee H; Vasoo S; Koh DR; Robless PA
    Clin Exp Rheumatol; 2011; 29(2):261-8. PubMed ID: 21385541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulatory osteoprotegerin is related to osteoporosis of the hip in patients with COPD.
    Pobeha P; Petrasova D; Tkacova R; Joppa P
    Respir Med; 2014 Apr; 108(4):621-7. PubMed ID: 24424018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of bisphosphonate might be important to improve bone mineral density in patients with rheumatoid arthritis even under tight control: the TOMORROW study.
    Tada M; Inui K; Sugioka Y; Mamoto K; Okano T; Anno S; Koike T
    Rheumatol Int; 2017 Jun; 37(6):999-1005. PubMed ID: 28405825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 25-hydroxyvitamin D and vitamin D-binding protein on bone mineral density and disease activity in Malaysian patients with rheumatoid arthritis.
    Wong TH; Gupta ED; Radhakrishnan AK; Gun SC; Chembalingam G; Yeap SS
    Int J Rheum Dis; 2018 May; 21(5):992-1000. PubMed ID: 28217867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detailed analyses of periarticular osteoporosis in rheumatoid arthritis.
    Alenfeld FE; Diessel E; Brezger M; Sieper J; Felsenberg D; Braun J
    Osteoporos Int; 2000; 11(5):400-7. PubMed ID: 10912841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.